申请人:Eickmeier Christian
公开号:US20060223759A1
公开(公告)日:2006-10-05
The present invention relates to substituted 1,2-ethylenediamines of general formula (I)
wherein the groups R
1
to R
15
, A, B, L, i as well as X
1
-X
4
are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.
本发明涉及通式(I)的取代1,2-乙二胺化合物,其中基团R1至R15,A,B,L,i以及X1-X4如规范和权利要求中所定义,并且其用于治疗阿尔茨海默病(AD)和类似疾病。